Files

Download

Download Full Text (379 KB)

Abstract

We present the results of a double-blinded randomized sham-controlled research study of a non-pharmacologic low back pain intervention. Calmare therapy is an neurocutanous electrical stimulation approach for pain management. The intervention group received Calmare therapy and the other received sham. Differences in pain severity and interference scores, pain sensitivity measures and gene expression profiles are reported. Patterns of downregulated gene expression suggest that Calmare may alter proteins involved in pain transduction may have implications for the treatment of other chronic pain conditions.

Publication Date

2015

Subject Major(s)

Nursing

Keywords

non-pharmacologic low back pain intervention, Calmare therapy, differential gene expression, pain transduction proteins

Disciplines

Neurosciences | Nursing

Current Academic Year

Senior

Faculty Advisor/Mentor

Angela Starkweather, Ph.D., ACNP-BC, CNRN

Faculty Advisor/Mentor

Amy Heineman, BSN, RN

Rights

© The Author(s)

Decreased Pain Severity and Differential Gene Expression Following Calmare Therapy

Share

COinS